Breast cancer metastatic – Basic Information

Go back

Metastatic breast cancer represents the most advanced stage of breast cancer, where cancer cells have traveled beyond the breast and nearby areas to distant parts of the body. While this diagnosis brings significant challenges and emotional weight, advances in medical treatment are helping more people live longer and fuller lives with this condition than ever before.

Understanding Metastatic Breast Cancer

Metastatic breast cancer, also known as advanced breast cancer or stage IV breast cancer, occurs when cancer cells from the original breast tumor spread to other organs or tissues in the body. This spreading process is called metastasis, which happens when cancer cells break away from where they started and travel through the bloodstream or lymphatic system (the network of vessels and nodes that help fight infection and remove waste from the body) to settle in distant locations.[1][2]

When breast cancer spreads to another part of the body, it remains breast cancer at the cellular level. For example, if breast cancer travels to the bones, the tumors in the bones are made up of breast cancer cells, not bone cancer cells. This is why doctors treat these distant tumors with breast cancer therapies rather than treatments designed for cancers that originally develop in those organs.[3]

The most common places where breast cancer spreads include the bones, lungs, liver, and brain. Each of these locations can cause different symptoms depending on how the cancer affects that particular organ. About 70% of all patients living with advanced breast cancer have bone metastases, making this the most frequent site of spread.[6]

Epidemiology

Around 170,000 women in the United States are currently living with metastatic breast cancer according to recent estimates. The U.S. National Cancer Institute projects that approximately 297,000 women and 2,800 men will receive a breast cancer diagnosis in 2023, though not all of these will be metastatic at the time of diagnosis.[2][11]

Metastatic breast cancer affects people in two main ways. Some individuals have metastatic disease when they first receive their breast cancer diagnosis, which occurs in about 6% to 10% of cases. This is called de novo metastatic breast cancer, meaning the cancer had already spread before it was discovered.[2][3][11]

However, most metastatic breast cancer develops as a recurrence, meaning it returns after initial treatment for earlier-stage breast cancer. According to data from the National Cancer Institute, about 20% to 30% of women diagnosed with early-stage breast cancer will later develop metastatic disease. This recurrence can happen months or even years after the original diagnosis and treatment. Nearly 30% of women diagnosed with early-stage breast cancer eventually develop metastatic disease at some point in their lives.[2][3]

While breast cancer is far more common in women, men can also develop metastatic breast cancer. Because male breast cancer is relatively rare, precise statistics about how many cases become metastatic are not as well established as they are for women.[3]

Causes

Most cases of metastatic breast cancer occur when the original treatment does not destroy all cancer cells in the body. Even when treatments successfully shrink tumors to the point where they cannot be detected by medical tests, some weakened cancer cells may survive. These cells might hide in nearby tissue, lymph nodes, or even enter the bloodstream before surgery removes the main tumor.[2]

After treatment ends, these surviving cancer cells can remain dormant in the body for extended periods. Over time, however, they may regain strength and begin to grow and multiply again. As they become more active, these cells can travel through the bloodstream and lymphatic system, which carry fluid throughout the body. This network of vessels and nodes essentially provides a transportation system that allows cancer cells to reach distant organs and tissues.[2][9]

Once cancer cells arrive at a new location in the body, they may settle there and form new tumors. In some cases, these metastatic tumors begin causing symptoms right away. In other situations, the cancer cells remain inactive for years before symptoms appear. Scientists and doctors do not yet fully understand why some cancer cells leave the original tumor while others stay, or why some traveling cells continue growing while others do not.[2][4]

Breast cancer generally develops by chance, without a specific identifiable cause in most cases. The main risk factors for developing breast cancer in the first place include age, hormones, and family history of the disease. Whether metastatic tumors will develop depends on various properties of the original tumor and is also more likely if the cancer was discovered at an advanced stage initially.[4]

⚠️ Important
Some people worry they might be partly responsible for cancer spreading because of their lifestyle choices. However, lifestyle factors generally play only a minor role in cancer metastasis once the disease has already developed. The spread of cancer is primarily a result of the disease’s biological behavior and the characteristics of the cancer cells themselves, not something caused by the patient’s actions or decisions.

Risk Factors

The likelihood that breast cancer will become metastatic depends on several factors related to the original tumor’s characteristics. The properties of the tumor itself play a significant role in determining whether cancer cells will spread to distant parts of the body. Cancers that are discovered at more advanced stages when first diagnosed carry a higher risk of already having spread or spreading later.[4]

Certain biological features of the cancer cells can influence the risk of metastasis. Metastatic breast cancer cells frequently differ from the original breast cancer cells in important properties such as receptor status (whether the cancer responds to hormones or specific proteins). These cells often develop resistance to several types of treatment and acquire special characteristics that help them survive the journey through the body and establish themselves in distant organs.[6]

The type of breast cancer also matters. For instance, about 20% of breast cancers are HER2-positive, meaning they have higher levels of a protein called human epidermal growth factor receptor 2. Understanding the specific characteristics of the cancer helps doctors predict its behavior and plan appropriate treatment strategies.[14]

Not all people with breast cancer will develop metastatic disease. In fact, the majority of people treated for early-stage breast cancer will not experience cancer spread to distant organs. However, understanding these risk factors helps medical teams monitor patients more carefully and intervene earlier if signs of metastasis appear.[2]

Symptoms

The symptoms of metastatic breast cancer vary greatly depending on where in the body the cancer has spread. It’s important to remember that many common physical issues like fatigue can be symptoms of the cancer itself or side effects of treatment, so not every change necessarily means the cancer is getting worse. However, certain specific symptoms may signal that cancer has spread to particular organs.[2][9]

When breast cancer spreads to the bones, people may experience sudden joint pain or bone pain that doesn’t go away. The bones may become weaker and break more easily in what doctors call pathological fractures. Some people notice numbness or muscle weakness in their arms and legs, or swelling in affected areas. Roughly 70% of patients with advanced breast cancer have bone metastases, making bone-related symptoms particularly common.[2][6][9]

Brain metastases can cause progressively worsening headaches or a feeling of pressure in the head. Vision changes such as double vision, blurred vision, or seeing flashes of light may occur. Some people experience seizures, nausea and vomiting, or changes in their behavior or personality. These symptoms happen because the growing tumors affect how the brain normally functions.[2][6][9]

When cancer reaches the lungs, the most common symptoms include a persistent cough that won’t go away, difficulty catching one’s breath (called dyspnea), and chest pain. Some people develop frequent chest infections as the tumors interfere with normal lung function.[2][6][9]

Liver metastases may cause jaundice (a yellowing of the skin and eyes), itchy skin or rash, stomach pain, loss of appetite, nausea, and vomiting. These symptoms occur because the liver cannot perform its normal functions when affected by cancer.[2][6][9]

Beyond these location-specific symptoms, people with metastatic breast cancer often experience more general symptoms. These include persistent and overwhelming fatigue that doesn’t improve with rest, a general feeling of being unwell (called malaise), unintended weight loss, and poor appetite. Many women notice these changes themselves, though sometimes a doctor identifies them during routine examinations.[4][6]

Sometimes people with metastatic breast cancer don’t experience any notable symptoms at all, and the spread is discovered through routine imaging tests or check-ups. This is why regular monitoring and follow-up appointments remain important even when someone feels well.[6]

Prevention

Once breast cancer has developed and been treated, there is no guaranteed way to prevent it from becoming metastatic. However, early detection and prompt treatment of the original breast cancer can reduce the risk of metastasis. Following through with all recommended treatments for early-stage breast cancer and attending regular follow-up appointments helps catch any recurrence as early as possible.[2]

For people already diagnosed with metastatic breast cancer, the focus shifts to managing the disease and maintaining quality of life rather than prevention. Regular monitoring through scans and tests helps doctors track how well treatments are working and make adjustments as needed. Being aware of new or changing symptoms and reporting them promptly to healthcare providers allows for quicker intervention when necessary.[3][8]

Some people find that taking an active role in their care helps them feel more in control of their situation. This includes learning about the disease, asking questions, participating in treatment decisions, and taking care of overall health through good nutrition, appropriate exercise when possible, and stress management. While these actions cannot prevent metastatic disease, they can contribute to better overall well-being and quality of life.[17][18]

Pathophysiology

Metastatic breast cancer develops through a complex series of biological changes that allow cancer cells to break free from the original tumor, survive a journey through the body, and establish new tumors in distant organs. Understanding these changes helps explain why metastatic cancer behaves differently than the original breast tumor.[6]

Cancer cells must overcome several environmental barriers to successfully metastasize. These barriers include physical obstacles like the basement membrane (a thin layer that separates tissues), chemical challenges such as oxygen-poor conditions and acidic environments, and biological defenses including the immune system’s attempts to destroy abnormal cells. The cancer cells that successfully navigate these challenges are often the most aggressive and treatment-resistant.[6]

As cancer cells prepare to spread, they undergo changes that help them degrade and break through the extracellular matrix, which is the structural framework that holds cells together. Cancer cells can produce enzymes and proteins that break down this framework, allowing them to escape the original tumor. Once free, these cells can enter blood vessels or lymphatic vessels, which serve as highways throughout the body.[6]

The pattern of where breast cancer spreads is not random. Blood flow patterns from the breast influence where circulating cancer cells might end up. Additionally, different organs produce specific chemical signals that can attract certain cancer cells, somewhat like a homing signal. This helps explain why breast cancer has preferred sites of metastasis, particularly bones, lungs, liver, and brain. Scientists call this the “seed and soil” hypothesis—cancer cells (the seeds) grow best in organs (the soil) that provide the right environment.[6]

When breast cancer spreads to bones, the cancer cells disrupt the normal process of bone maintenance. Healthy bones constantly break down old bone tissue and build new bone tissue in a balanced cycle. Cancer cells can tip this balance, leading to either excessive bone breakdown or abnormal bone formation. This disruption causes the pain and weakness that many people with bone metastases experience.[6]

Brain metastases involve cancer cells that manage to cross the blood-brain barrier, a protective shield that normally prevents harmful substances from entering brain tissue. Only certain cancer cells acquire the ability to penetrate this barrier. Once in the brain, these cells can cause swelling and increased pressure inside the skull, leading to the neurological symptoms people experience.[6]

An important aspect of metastatic disease is that the cancer cells often change over time. They may lose or gain receptors for hormones or other proteins, which means a metastatic tumor might respond differently to treatments than the original breast tumor did. This is why doctors sometimes perform biopsies of metastatic tumors to check their current characteristics and adjust treatment accordingly.[6]

Another puzzling aspect of metastasis is dormancy. Some cancer cells can remain inactive in distant organs for years without growing or causing symptoms. What triggers these dormant cells to suddenly become active again remains one of the great mysteries in cancer research. This dormancy helps explain why some people experience recurrence many years after their original cancer treatment appeared successful.[2][9]

Ongoing Clinical Trials on Breast cancer metastatic

  • Study of melphalan followed by eribulin, vinorelbine, or capecitabine versus eribulin, vinorelbine, or capecitabine alone for metastatic breast cancer patients with liver disease

    Recruiting

    1 1 1
    Investigated diseases:
    Italy Spain
  • A Study Comparing GDC-4198 Alone and with Giredestrant versus Abemaciclib with Giredestrant for Advanced Breast Cancer After Previous CDK4/6 Treatment

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Spain
  • Study of inavolisib and fulvestrant for patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Spain
  • Study of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Bulgaria Czechia Finland France Germany +8
  • Study of Trastuzumab Deruxtecan Blood Levels in Normal Weight and Overweight Patients with Metastatic Breast Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of 177Lu-FAP-2286 alone and with drug combinations for patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer

    Recruiting

    1 1 1
    Belgium France Italy Spain
  • Study on the Impact of Exercise and Atorvastatin on Advanced Breast, Ovarian, Prostate, and Kidney Cancer Patients

    Recruiting

    1 1 1 1
    Investigated drugs:
    Finland
  • Study on zAvatar Test for Treatment Decisions in Relapsed Ovarian Cancer and Metastatic Breast Cancer Using Palbociclib and Drug Combination for Eligible Patients

    Recruiting

    1 1 1 1
    Portugal
  • Study on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment

    Recruiting

    1 1 1 1
    Investigated diseases:
    Austria Belgium France Germany Greece Italy +2
  • Study on the Safety and Effects of Vosilasarm Alone and in Combination for Patients with Relapsed Advanced or Metastatic Breast Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

References

https://www.nationalbreastcancer.org/metastatic-breast-cancer/

https://my.clevelandclinic.org/health/diseases/21497-metastatic-breast-cancer

https://www.breastcancer.org/types/metastatic

https://www.ncbi.nlm.nih.gov/books/NBK361001/

https://www.komen.org/breast-cancer/metastatic/

https://en.wikipedia.org/wiki/Metastatic_breast_cancer

https://www.bcrf.org/about-breast-cancer/metastatic-breast-cancer-symptoms-treatment/

https://www.breastcancer.org/types/metastatic/treatment

https://my.clevelandclinic.org/health/diseases/21497-metastatic-breast-cancer

https://www.ncbi.nlm.nih.gov/books/NBK13196/

https://www.komen.org/breast-cancer/metastatic/metastatic/

https://cancer.ca/en/cancer-information/cancer-types/breast/treatment/metastatic

https://www.cancerresearchuk.org/about-cancer/breast-cancer/secondary/treatment-options

https://www.dana-farber.org/newsroom/features/can-metastatic-breast-cancer-be-cured

https://www.breastcancer.org/types/metastatic/life-with-metastatic

https://www.breastcancer.org/types/metastatic/life-with-metastatic/tips-for-moving-forward

https://www.lbbc.org/your-journey/living-with-metastatic-breast-cancer/living-well-with-metastatic-breast-cancer

https://www.komen.org/blog/four-tips-for-living-well-with-metastatic-breast-cancer/

https://www.ncbi.nlm.nih.gov/books/NBK361014/

https://www.lifebeyondpink.com/

https://www.nationalbreastcancer.org/breast-cancer-stage-4/

https://www.cancer.org/cancer/latest-news/top-exercises-that-improve-quality-of-life-for-people-with-metastatic-breast-cancer.html

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can metastatic breast cancer be cured?

Currently, there is no cure for metastatic breast cancer. However, it can be treated, sometimes for many years, and treatment continues to improve. While the disease cannot be completely eliminated, many people live long, productive lives with ongoing treatment that controls the cancer and maintains quality of life.

How long can someone live with metastatic breast cancer?

The survival time varies greatly among individuals and depends on many factors including where the cancer has spread, the cancer’s characteristics, treatment response, and overall health. The median survival is 2 to 3 years, but some people live much longer. Patients who achieve complete remission with treatment and those with hormone receptor-positive tumors often have longer survival times. Thanks to newer treatments, people are living longer than ever before.

Why does breast cancer come back in other parts of the body?

Breast cancer returns in distant organs because some cancer cells survived the original treatment and traveled through the bloodstream or lymphatic system to other parts of the body. These cells can remain dormant for extended periods before becoming active again. Even when surgery removes a tumor and treatment shrinks it to undetectable levels, microscopic cancer cells may have already entered the bloodstream before or during treatment.

What is the difference between stage 4 breast cancer and metastatic breast cancer?

Stage 4 breast cancer and metastatic breast cancer are the same thing. Both terms describe breast cancer that has spread beyond the breast and nearby lymph nodes to distant parts of the body such as bones, lungs, liver, or brain. The terms are used interchangeably, and both are also called advanced breast cancer.

Does everyone with early-stage breast cancer eventually develop metastatic disease?

No, not everyone with early-stage breast cancer will develop metastatic disease. According to data, about 20% to 30% of women with early-stage cancer later develop metastatic breast cancer, meaning that 70% to 80% do not. Many people successfully treated for early-stage breast cancer never experience a recurrence or spread to distant organs.

🎯 Key takeaways

  • Approximately 170,000 women in the United States are currently living with metastatic breast cancer, and newer treatments are helping them live longer than ever before.
  • When breast cancer spreads to another organ, it remains breast cancer and is treated with breast cancer therapies, not with treatments for the organ where it has spread.
  • About 6% to 10% of people have metastatic disease at their first breast cancer diagnosis, while most metastatic cancer develops as a recurrence years after initial treatment.
  • Bones are the most common site of breast cancer metastasis, affecting roughly 70% of patients with advanced disease, followed by lungs, liver, and brain.
  • Symptoms of metastatic breast cancer vary dramatically based on where the cancer has spread, from bone pain and fractures to headaches, breathing difficulties, or jaundice.
  • Cancer cells can remain dormant in the body for years before becoming active, and scientists still don’t fully understand what triggers this reactivation.
  • Only 20% to 30% of women with early-stage breast cancer eventually develop metastatic disease, meaning most people treated for breast cancer will not experience distant spread.
  • Lifestyle factors play only a minor role in cancer metastasis—the spread is primarily due to the biological behavior of cancer cells, not patient actions or choices.

Connected medications: